Related Experiment Video

Updated: Aug 14, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Current status and future perspectives of platelet function-guided precision antiplatelet therapy for patients with

Guoliang Zhu1, Xiaoling Chen1,2, Xinyi Huang3

  • 1Department of Neurology, Sichuan Provincial People's Hospital, School of Medicine University of Electronic Science and Technology of China Chengdu China.

Neuroprotection (Chichester, England)
|August 13, 2026
PubMed

Insights

Individualized antiplatelet therapy is crucial for preventing cerebral infarction. Platelet function testing (PFT) shows promise for optimizing antiplatelet treatment, reducing risks of stroke and bleeding.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacogenomics

Background:

  • Antiplatelet therapy is vital for secondary prevention of cerebral infarction.
  • Drug resistance and excessive inhibition lead to ischemic or bleeding events, limiting clinical benefits.
  • Current genetic testing (CYP2C19) is insufficient for managing these risks.

Purpose of the Study:

  • To review the current evidence and application of Platelet Function Testing (PFT)-guided antiplatelet therapy for cerebral infarction.
  • To explore PFT's potential in overcoming drug resistance and guiding de-escalation strategies.
  • To identify variability in PFT application and suggest future research directions.

Main Methods:

  • Review of current literature on PFT-guided antiplatelet therapy in cerebral infarction.
  • Analysis of PFT's role in managing drug resistance and preventing ischemic/bleeding events.
  • Examination of CYP2C19 genetic polymorphisms in relation to antiplatelet efficacy.

Main Results:

  • PFT offers a direct measure of antiplatelet effects, potentially improving outcomes.
  • While beneficial post-PCI, PFT's efficacy in cerebral infarction patients is debated.
  • Significant variability exists in the current application of PFT for personalized antiplatelet regimens.

Conclusions:

  • Platelet function testing holds promise for personalized antiplatelet therapy in cerebral infarction.
  • Further research is needed to standardize PFT application and confirm its benefits in this patient population.
  • Optimizing antiplatelet therapy through PFT can mitigate both ischemic and bleeding complications.

Keywords:
cerebral infarctionplatelet aggregation inhibitorsplatelet function testsprecision medicine

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...